The 1st Participant in A New CHECK-NIRS Clinical Study is Enrolled!
Stefan Hof, Clinical scientist and anesthesiologist at University Hospital of Düsseldorf, shared on LinkedIn:
”Together with our medical doctoral candidate Annalena Müllers we enrolled the first participant in our new clinical study – the CHECK-NIRS study.
In this project, we will systematically investigate external and behavioural factors influencing NIRS-based 2D-imaging.
This marks an important first step in translating our predominantly experimental findings into clinical application, with the goal of gaining deeper insights into tissue oxygenation in humans.
I am particularly looking forward to collaborating with Patricia Wischmann from the Department of Cardiology, Pneumology and Angiology at University Hospital Düsseldorf, Kalman Bodis from the Department of Endocrinology and Diabetology at University Hospital Düsseldorf and Katharina Post from inovex GmbH.
A big thank you to everyone involved for your dedication and teamwork!”
Stay updated with Hemostasis Today.
-
Dec 19, 2025, 13:30PPTA Europe’s Holiday Message: Wishing Health, Rest, and Renewal for 2026
-
Dec 19, 2025, 13:22If You Were Reading a “Bible for Blood Donation Volunteers,” What’s the ONE Thing That Must Be in It?
-
Dec 19, 2025, 12:52Julia Owens: Stroke Remains One of the World’s Leading Causes of Death and Disability
-
Dec 19, 2025, 12:03Pradeep Natarajan: Our New Genetic Study of Aortic Stenosis in ~3M
-
Dec 19, 2025, 11:47ESO Blog: Anna Gardin on Stroke Risk in the Era of Climate Extremes
-
Dec 19, 2025, 10:51Sarah Elkourashy Presents Insights on Caplacizumab for TTP at ASH25
-
Dec 19, 2025, 10:08Camilla Lombardi Shares an EHC Nutrition Guide for People with Bleeding Disorders
-
Dec 19, 2025, 09:56Danny Hsu Shares The ”I-WISh” Study by Nichola Cooper on ITP
-
Dec 19, 2025, 09:39Paul Bolaji: A Landmark Achievement -The Historic 1st Nigerian Stroke Leaders’ Summit 2025